Delivery Order SPE2DB22D1017-SPE2DB24FF8DT
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, with a ceiling value of $3,879.78, is for the delivery of COSENTYX SENSOREADY 150 MG PEN medication and has a completion date of June 24, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,611.14, is a delivery order for the supply of COSENTYX SENSOREADY 150 MG PENML. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $35,464.71 firm fixed-price delivery order is for the supply of COSENTYX SENSOREADY 150 MG PENML, a specialty pharmaceutical product. Amerisourcebergen, a leading pharmaceutical distributor, is providing these critical medical supplies under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $16,221.56 firm-fixed-price delivery order is for the supply of COSENTYX SENSOREADY 150 MG PEN injections, with a period of performance through May 13, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $15,710.80, is for the delivery of COSENTYX SENSOREADY 150 MG PEN ML, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 21, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division,...
- This federal contract award was issued by the Department of Defense's (DoD) Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,389.14 Firm Fixed Price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a prescription medication. Amerisourcebergen's Corporate Office Division, a subsidiary of Cencora, Inc., was awarded this order without a set-aside designation. Amerisourcebergen also holds a...
- This federal contract award, valued at $3,105.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,566,053,958 units of COSENTYX SENSOREADY 150 MG PEN/ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,909.55 delivery order contract is for the supply of COSENTYX SENSOREADY 150 MG PENML, a medication used to treat various medical conditions. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order worth $3,043.90 for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products. The contract, valued at $3,043.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF8DTDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,043.90 firm fixed-price delivery order is for the supply of COSENTYX SENSOREADY 150 MG PEN medication and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 5/22/24 |